000 01065 a2200313 4500
005 20250516001443.0
264 0 _c20121108
008 201211s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2010.027151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZenz, Thorsten
245 0 0 _aBiological diversity and risk-adapted treatment of chronic lymphocytic leukemia.
_h[electronic resource]
260 _bHaematologica
_cSep 2010
300 _a1441-3 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aCell Proliferation
650 0 4 _aChromosome Aberrations
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xgenetics
650 0 4 _aLymph Nodes
_xpathology
650 0 4 _aMale
650 0 4 _aReceptors, Antigen, B-Cell
700 1 _aMertens, Daniel
700 1 _aStilgenbauer, Stephan
773 0 _tHaematologica
_gvol. 95
_gno. 9
_gp. 1441-3
856 4 0 _uhttps://doi.org/10.3324/haematol.2010.027151
_zAvailable from publisher's website
999 _c20141355
_d20141355